Related Experiment Video
Updated: Sep 3, 2026

Examining the Role of Nasopharyngeal-associated Lymphoreticular Tissue (NALT) in Mouse Responses to Vaccines
Published on: August 1, 2012
[The treatment of nasal (nasal-type) NK-T cell lymphoma]
Canmin Wang1, Suqin Zhang, Zhaoji Li
1Department of Otolaryngology, Changhai Hospital, Second Military Medical University, Shanghai 200433.
Objective:
To discuss the treatment of nasal (nasal-type) NK-T cell lymphoma.
Method:
From 1993 to 2000, there were twenty one nasal (nasal-type) NK-T cell lymphoma patients treated in our department, three patients were treated with only radiotherapy, eighteen patients were treated combination radiotherapy with chemotherapy, and all patients were followed up for 1-8 years.
Result:
Eleven patients completely alleviated, six patients partial alleviated, four aggravated and two died.
Conclusion:
The prognosis of nasal (nasal-type) NK-T cell lymphoma is not satisfactory. The combination therapy for it is the optimal at present.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy

